Nordic Capital

Nordic Capital is a Stockholm-headquartered private equity firm with a substantial global healthcare practice covering both buyouts and growth equity. Healthcare sub-vertical focus spans Care Delivery and Tech-Enabled Services as well as Pharma and Therapeutics, reflecting the firm’s appetite for both services platforms and life sciences exposure. AI is not a standalone thesis.

Check sizes are $25M and above at the growth stage, with the firm capable of leading much larger transactions. Geographic reach is global with particular strength in Europe and a meaningful US presence. Specific portfolio companies and named team members are not included in the data available here; Nordic Capital’s deal page is the appropriate reference for current activity in any given sub-sector.

For founders, Nordic Capital is a conversation for scaled, established companies, not early-stage AI bets. Healthcare software founders pre-Series C will not be in scope. Where Nordic is genuinely interesting is for European pharma services, specialty pharma, contract manufacturing, or large clinical services platforms considering a control transaction or a growth investment from a sponsor with cross-border execution capability. Approach with a clear path to profitable scale and an explicit thesis on what European platform leverage adds to your business.